Category: Vaccine Headlines
(STAT) A clinical trial of vaccines targeting the Ebola Sudan virus is starting this week in Uganda, with first doses going into arms potentially on Tuesday. Already, though, this effort has taught the World Health Organization and partners two important lessons. They’ve learned they can get clinical trials to test countermeasures for rare but dangerous […]
Dec 13, 2022
When You Get Your Flu Shot And COVID Shot At The Same Time, This Is What Happens To Your Body
(MSN) Considering how health experts are forecasting a high number of flu cases even as we are still battling COVID-19, many are advocating for eligible people to get the flu vaccine and the new COVID-19 booster shot at the same time. But what happens to your body if you get these two doses simultaneously? While you may […]
Dec 9, 2022
Flu vaccine appears to be a very good match to circulating strains, CDC says
(KSL Utah) This year’s flu shot appears to be “a very good match” to the circulating strains, U.S. Centers for Disease Control and Prevention Director Dr. Rochelle Walensky said at a news briefing Monday. However, she noted that flu vaccinations are lagging behind the pace of previous years. Through the end of October, CDC data shows that […]
Dec 9, 2022
(Pfizer) Pfizer and BioNTech today announced that the companies have submitted an application to the U.S. Food and Drug Administration (FDA) for emergency use authorization (EUA) of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine as the third 3-µg dose in the three-dose primary series for children 6 months through 4 years of age. With the high […]
Dec 5, 2022
One Step Closer to a Universal Flu Vaccine?
(NYT) Scientists have tested in animals a vaccine that may protect against 20 strains of influenza, helping to prevent another pandemic. A new study describes successful animal tests of just such a vaccine, offering hope that the country can be protected against future flu pandemics. Like the Covid vaccines made by Pfizer-BioNTech and Moderna, the […]
Nov 29, 2022
The End of Vaccines at ‘Warp Speed’
(New York Times) Financial and bureaucratic barriers in the United States mean that the next generation of Covid vaccines may well be designed here, but used elsewhere. Operation Warp Speed, the Trump-era program that poured billions of dollars into developing Covid shots, seemed to signal a new dawn of American vaccine making, demonstrating how decades […]
Nov 21, 2022
Vaccine Breakthrough Could Finally Bring COVID to Its Knees
(DailyBeast) With new COVID variants and subvariants evolving faster and faster, each chipping away at the effectiveness of the leading vaccines, the hunt is on for a new kind of vaccine—one that works equally well on current and future forms of the novel coronavirus. Now researchers at the National Institutes of Health in Maryland think they’ve found a […]
Nov 21, 2022
Can mRNA vaccines transform the fight against Ebola?
(Nature) COVID-19 vaccines that rely on mRNA technology are credited with transforming humanity’s fight against the coronavirus pandemic. The vaccines — one made by drug giant Pfizer with German biotech firm BioNTech, another by US pharmaceutical company Moderna — sped through clinical trials in just months and gained approval from major regulatory bodies less than a year after […]
Nov 14, 2022
(Pfizer) today announced the advancement of an mRNA-based combination vaccine candidate for influenza and COVID-19 to a Phase 1 trial with the aim to address two severe respiratory diseases with one vaccine. The first participant has been dosed in a Phase 1 trial evaluating the safety, tolerability, and immunogenicity of a nucleoside-modified RNA (modRNA)-based combination […]
Nov 4, 2022
Pfizer, BioNTech say bivalent COVID-19 booster shot performs better against BA.5 omicron subvariant
(ABC News) American pharmaceutical company Pfizer and its German partner BioNTech announced Friday that a booster dose of their bivalent COVID-19 vaccine performs better against two circulating versions of the omicron variant, compared with a booster shot of their original vaccine.According to a joint press release, updated data from a Phase 2-3 clinical trial shows […]
Nov 4, 2022